

"A neuropsychology based technology company delivering digital solutions for CNS clinical trials"
P1vital provides digital health technology and neuroscience research services to improve clinical trial outcomes in central nervous system disorders. The company's electronic Clinical Outcome Assessment platform and validated cognitive tasks enable pharmaceutical and healthcare organisations to capture more accurate endpoint data, reduce user burden, and strengthen signal detection in CNS studies. P1vital combines over 20 years of CNS drug development expertise with objective digital biomarkers. Their solutions include bespoke eCOA configuration, performance rated outcomes covering emotional processing and cognitive function, and full service scientific support from study design through analysis and reporting.


18
Team Members
2004
Founded
Digital Health
Sector
Hybrid
Work Environment
A future where CNS treatment development is guided by objective, digitally captured biomarkers that accelerate the path from research to patient benefit.
At P1vital, our mission is to use CNS drug development and neuroscience knowledge in combination with digital technology to enhance clinical insights.